The American Diabetes Association/Jdrf Type 1 Diabetes Sourcebook
Editat de Anne L. Peters, Lori M. Laffelen Limba Engleză Hardback – 28 mar 2013
Preț: 154.51 lei
Preț vechi: 203.09 lei
-24% Nou
Puncte Express: 232
Preț estimativ în valută:
29.57€ • 30.82$ • 24.62£
29.57€ • 30.82$ • 24.62£
Carte indisponibilă temporar
Doresc să fiu notificat când acest titlu va fi disponibil:
Se trimite...
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781580404785
ISBN-10: 1580404782
Pagini: 576
Dimensiuni: 155 x 231 x 33 mm
Greutate: 1.18 kg
Ediția:New.
Editura: American Diabetes Association
ISBN-10: 1580404782
Pagini: 576
Dimensiuni: 155 x 231 x 33 mm
Greutate: 1.18 kg
Ediția:New.
Editura: American Diabetes Association
Cuprins
I: Natural History of Type 1 Diabetes
Chapter 1: Overview of Type 1 Diabetes
Chapter 2: Natural History of Prediction of Type 1 Diabetes
Chapter 3: Medical Interdiction
Chapter 4: Beta Cell Replacement
II: Assessment
Chapter 5: Initial Evaluation and Follow-Up
III: Targets
Chapter 6: Targets
IV: Treatment
Chapter 7: Delivery of Education and Supporting Self-Management
Chapter 8: Assessment and Treatment of Psychosocial Issues
Chapter 9: Monitoring
Chapter 10: Nutrition
Chapter 11: Exercise
Chapter 12: Use of Insulin
Chapter 13: Adjunctive Therapies
V: Prevention and Management of Acute Complications
Chapter 14: Hypoglycemia
Chapter 15: Diabetes Ketoacidosis
VI: Screening, Prevention, and Management of Chronic Conditions
Chapter 16: Complications: Detection and Management
Chapter 17: Preconception: From Fertility to Menopause
VII: Diabetes Mellitus in Special Settings
Chapter 18A: Inpatient
Chapter 18B: Schools/Day Care
Chapter 18C: Camps
Chapter 18D: Employment/Shift Work
Chapter 18E: Nursing Homes
Chapter 18F: Geriatric Populations
Chapter 18G: Special Population Groups
Chapter 18H: Developing Countries
Chapter 1: Overview of Type 1 Diabetes
Chapter 2: Natural History of Prediction of Type 1 Diabetes
Chapter 3: Medical Interdiction
Chapter 4: Beta Cell Replacement
II: Assessment
Chapter 5: Initial Evaluation and Follow-Up
III: Targets
Chapter 6: Targets
IV: Treatment
Chapter 7: Delivery of Education and Supporting Self-Management
Chapter 8: Assessment and Treatment of Psychosocial Issues
Chapter 9: Monitoring
Chapter 10: Nutrition
Chapter 11: Exercise
Chapter 12: Use of Insulin
Chapter 13: Adjunctive Therapies
V: Prevention and Management of Acute Complications
Chapter 14: Hypoglycemia
Chapter 15: Diabetes Ketoacidosis
VI: Screening, Prevention, and Management of Chronic Conditions
Chapter 16: Complications: Detection and Management
Chapter 17: Preconception: From Fertility to Menopause
VII: Diabetes Mellitus in Special Settings
Chapter 18A: Inpatient
Chapter 18B: Schools/Day Care
Chapter 18C: Camps
Chapter 18D: Employment/Shift Work
Chapter 18E: Nursing Homes
Chapter 18F: Geriatric Populations
Chapter 18G: Special Population Groups
Chapter 18H: Developing Countries
Notă biografică
Anne L. Peters is the director of the USC Clinical Diabetes Program. Dr. Peters received her medical degree from the University of Chicago Pritzker School of Medicine before proceeding to Stanford University Medical Center in Palo Alto, California, to perform her internship and residency in internal medicine. She completed an endocrinology fellowship at Cedars-Sinai Medical Center in Los Angeles. She was in charge of the Comprehensive Diabetes Program at Cedars and then moved to UCLA, where she ran the Clinical Diabetes Program there. Because of an interest in working with the underserved, she subsequently moved to USC.
Dr. Peters is involved in numerous professional organizations and activities, including the American Board of Internal Medicine (Endocrine Subspecialty Board), American College of Physicians, JDRF and the American Diabetes Association, among others. She is currently is a reviewer for Diabetes Care, JAMA and many other journals. She is a member of the ADA Publications Committee and as the Scientific Sessions Planning Committee.
Lori M. Laffel is Chief of the Pediatric, Adolescent and Young Adult Section at the Joslin Clinic, and an Investigator in the Section on Genetics and Epidemiology at the Joslin Diabetes Center (Boston), as well as an Associate Professor of Pediatrics at Harvard Medical School. She has been the Principal Investigator and Program Director of Joslin’s NIH-funded postdoctoral fellowship and early career development training grants for pediatric endocrinologists entering the field of diabetes research.
She is actively involved with the American Diabetes Association, as a member of the Boston Leadership Board, a recent past member of the National Board of Directors of the American Diabetes Association, the National Committee for Pediatric Guidelines, chair on the ADA’s Working Group on Transitions in Care for Young Adults with Diabetes, and she is chair of the ADA’s Youth Strategies Committee. She also has been a member of the Advisory Board of the International Society of Pediatric and Adolescent Diabetes. She is on the Clinical Advisory Committee for the Juvenile Diabetes Research Foundation.
Dr. Laffel received her medical degree from the University of Miami School of Medicine and her master’s degree in Public Health from the Harvard School of Public Health. She did her pediatric training at Children’s Hospital and
her fellowship training at Children’s Hospital and Joslin.
Jane L. Chiang graduated from Case Western Reserve University School of Medicine and then did a pediatrics residency at the University of California, Los Angeles. She completed a fellowship in pediatric endocrinology at the University of California at San Francisco, where she studied transcription factors involved in beta cell development.
She stayed at UCSF as a pediatric faculty member until 2005, when she joined Genentech where she played a key role in the development of novel type 1 diabetes therapeutics. She briefly joined the JDRF as Vice President of Clinical Development overseeing clinical development/medical affairs. Dr. Chiang's experience with diabetes research and leading complex projects has helped guide this unique collaborative project.
Dr. Peters is involved in numerous professional organizations and activities, including the American Board of Internal Medicine (Endocrine Subspecialty Board), American College of Physicians, JDRF and the American Diabetes Association, among others. She is currently is a reviewer for Diabetes Care, JAMA and many other journals. She is a member of the ADA Publications Committee and as the Scientific Sessions Planning Committee.
Lori M. Laffel is Chief of the Pediatric, Adolescent and Young Adult Section at the Joslin Clinic, and an Investigator in the Section on Genetics and Epidemiology at the Joslin Diabetes Center (Boston), as well as an Associate Professor of Pediatrics at Harvard Medical School. She has been the Principal Investigator and Program Director of Joslin’s NIH-funded postdoctoral fellowship and early career development training grants for pediatric endocrinologists entering the field of diabetes research.
She is actively involved with the American Diabetes Association, as a member of the Boston Leadership Board, a recent past member of the National Board of Directors of the American Diabetes Association, the National Committee for Pediatric Guidelines, chair on the ADA’s Working Group on Transitions in Care for Young Adults with Diabetes, and she is chair of the ADA’s Youth Strategies Committee. She also has been a member of the Advisory Board of the International Society of Pediatric and Adolescent Diabetes. She is on the Clinical Advisory Committee for the Juvenile Diabetes Research Foundation.
Dr. Laffel received her medical degree from the University of Miami School of Medicine and her master’s degree in Public Health from the Harvard School of Public Health. She did her pediatric training at Children’s Hospital and
her fellowship training at Children’s Hospital and Joslin.
Jane L. Chiang graduated from Case Western Reserve University School of Medicine and then did a pediatrics residency at the University of California, Los Angeles. She completed a fellowship in pediatric endocrinology at the University of California at San Francisco, where she studied transcription factors involved in beta cell development.
She stayed at UCSF as a pediatric faculty member until 2005, when she joined Genentech where she played a key role in the development of novel type 1 diabetes therapeutics. She briefly joined the JDRF as Vice President of Clinical Development overseeing clinical development/medical affairs. Dr. Chiang's experience with diabetes research and leading complex projects has helped guide this unique collaborative project.
Descriere
The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook serves as both an evidence-based reference work and consensus report outlining the most critical components of care for individuals with type 1 diabetes throughout their lifespan. The volume serves not only as a comprehensive guide for clinicians, but also reviews the evidence supporting these components of care and provides a perspective on the critical areas of research that are needed to improve our understanding of type 1 diabetes diagnosis and treatment. The volume focuses specifically on the needs of patients with type 1 diabetes and provides clear and detailed guidance on the current standards for the optimal treatment of type 1 diabetes from early childhood to later life.
To accomplish the book’s editorial goals, Editors-in-Chief, Drs. Anne Peters and Lori Laffel, assembled an editorial steering committee of prominent research physicians, clinicians, and educators to develop the topical coverage. In addition, a Managing Editor was brought on to help the authors write and focus their chapters.
To accomplish the book’s editorial goals, Editors-in-Chief, Drs. Anne Peters and Lori Laffel, assembled an editorial steering committee of prominent research physicians, clinicians, and educators to develop the topical coverage. In addition, a Managing Editor was brought on to help the authors write and focus their chapters.